Effects of Alzheimer's peptide and α1-antichymotrypsin on astrocyte gene expression

Neurobiology of Aging

Volumn 28, Issue 1, 2007, Pages 51-61

  Baker, Crystal ^a   Nielsen, Henrietta M ^b   Minthon, Lennart ^b   Wright, H T ^c   Chappell, Sally ^a   Okyere, John ^a   May, Sean ^a   Morgan, Kevin ^a   Kalsheker, Noor ^a   Janciauskiene, Sabina M ^b  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b LUND UNIVERSITY   (Sweden)

^c VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

1 Antichymotrypsin; Alzheimer's disease; Alzheimer's peptide (A 42); Astrocytes; Gene expression; Inflammation

Indexed keywords

ALPHA 1 ANTICHYMOTRYPSIN; AMYLOID BETA PROTEIN[1-42];

ALZHEIMER DISEASE; APOPTOSIS; ARTICLE; ASTROCYTE; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; NERVOUS SYSTEM DEVELOPMENT; PATHOGENESIS; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UPREGULATION;

ALPHA 1-ANTICHYMOTRYPSIN; AMYLOID BETA-PROTEIN; ASTROCYTES; CELLS, CULTURED; GENE EXPRESSION; HUMANS; PEPTIDE FRAGMENTS; PROTEOME;

EID: 33751226575     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2005.10.017     Document Type: Article

References (49)

1. Abraham C.R. Reactive astrocytes and alpha1-antichymotrypsin in Alzheimer's disease. Neurobiol Aging 22 (2001) 931-936
2. Abraham C.R., Selkoe D.J., and Potter H. Immunochemical identification of the serine protease inhibitor alpha 1-antichymotrypsin in the brain amyloid deposits of Alzheimer's disease. Cell 52 (1988) 487-501
3. Akiyama H., Barger S., Barnum S., Bradt B., Bauer J., Cole G.M., et al. Inflammation and Alzheimer's disease. Neurobiol Aging 21 (2000) 383-421
4. Berdnik D., Torok T., Gonzalez-Gaitan M., and Knoblich J.A. The endocytic protein [alpha]-adaptin is required for Numb-mediated asymmetric cell division in Drosophila. Dev Cell 3 (2002) 221-231
5. Castegna A., Aksenov M., Thongboonkerd V., Klein J.B., Pierce W.M., Booze R., et al. Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain. Part II: dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71. J Neurochem 82 (2002) 1524-1532
6. Cayouette M., and Raff M. Asymmetric segregation of Numb: a mechanism for neural specification from Drosophila to mammals. Nat Neurosci 5 (2002) 1265-1269
7. Haass C. Take five-BACE and the gamma-secretase quartet conduct Alzheimer's amyloid beta-peptide generation. EMBO J 23 (2004) 483-488
8. Haass C., Schlossmacher M.G., Hung A.Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B.L., et al. Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature 359 (1992) 322-325
9. Hamazaki H. Ca(2+)-dependent binding of human serum amyloid P component to Alzheimer's beta-amyloid peptide. J Biol Chem 270 (1995) 10392-10394
10. Herber D.L., Roth L.M., Wilson D., Wilson N., Mason J.E., Morgan D., et al. Time-dependent reduction in Abeta levels after intracranial LPS administration in APP transgenic mice. Exp Neurol 190 (2004) 245-253
11. Hinerfeld D., Traini M.D., Weinberger R.P., Cochran B., Doctrow S.R., Harry J., et al. Endogenous mitochondrial oxidative stress: neurodegeneration, proteomic analysis, specific respiratory chain defects, and efficacious antioxidant therapy in superoxide dismutase 2 null mice. J Neurochem 88 (2004) 657-667
12. Jafar-Nejad H., Norga K.K., and Bellen H.J. Numb: adapting notch for endocytosis. Dev Cell 3 (2002) 155-156
13. Jakymiw A., Raharjo E., Rattner J.B., Eystathioy T., Chan E.K., and Fujita D.J. Identification and characterization of a novel Golgi protein, golgin-67. J Biol Chem 275 (2000) 4137-4144
14. Janciauskiene S., Eriksson S., and Wright H.T. A specific structural interaction of Alzheimer's peptide A beta 1-42 with alpha 1-antichymotrypsin. Nat Struct Biol 3 (1996) 668-671
15. Janciauskiene S., Rubin H., Lukacs C.M., and Wright H.T. Alzheimer's peptide Abeta1-42 binds to two beta-sheets of alpha1-antichymotrypsin and transforms it from inhibitor to substrate. J Biol Chem 273 (1998) 28360-28364
16. Janciauskiene S., and Wright H.T. Inflammation antichymotrypsin, and lipid metabolism: autogenic etiology of Alzheimer's disease. Bioessays 20 (1998) 1039-1046
17. Juven-Gershon T., Shifman O., Unger T., Elkeles A., Haupt Y., and Oren M. The Mdm2 oncoprotein interacts with the cell fate regulator Numb. Mol Cell Biol 18 (1998) 3974-3982
18. Lahiri D.K., and Greig N.H. Lethal weapon: amyloid [beta]-peptide, role in the oxidative stress and neurodegeneration of Alzheimer's disease. Neurobiol Aging 25 (2004) 581-587
19. Li C., and Hung Wong W. Model-based analysis of oligonucleotide arrays: model validation, design issues and standard error application. Genome Biol 2 (2001) RESEARCH0032
20. Li C., and Wong W.H. Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection. Proc Natl Acad Sci USA 98 (2001) 31-36
21. Licastro F., Pedrini S., Caputo L., Annoni G., Davis L.J., Ferri C., et al. Increased plasma levels of interleukin-1, interleukin-6 and alpha-1-antichymotrypsin in patients with Alzheimer's disease: peripheral inflammation or signals from the brain?. J Neuroimmunol 103 (2000) 97-102
22. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
23. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25 4 (2001) 402-408
24. Lubec G., Nonaka M., Krapfenbauer K., Gratzer M., Cairns N., and Fountoulakis M. Expression of the dihydropyrimidinase related protein 2 (DRP-2) in Down syndrome and Alzheimer's disease brain is downregulated at the mRNA and dysregulated at the protein level. J Neural Transm Suppl 57 (1999) 161-177
25. Mandybur T.I., and Chuirazzi C.C. Astrocytes and the plaques of Alzheimer's disease. Neurology 40 (1990) 635-639
26. McGeer P.L., Itagaki S., Tago H., and McGeer E.G. Reactive microglia in patients with senile dementia of the Alzheimer type are positive for the histocompatibility glycoprotein HLA-DR. Neurosci Lett 79 (1987) 195-200
27. McGill M.A., and McGlade C.J. Mammalian Numb proteins promote notch1 receptor ubiquitination and degradation of the Notch1 intracellular domain. J Biol Chem 278 (2003) 23196-23203
28. Mucke L., Yu G.Q., McConlogue L., Rockenstein E.M., Abraham C.R., and Masliah E. Astroglial expression of human alpha(1)-antichymotrypsin enhances alzheimer-like pathology in amyloid protein precursor transgenic mice. Am J Pathol 157 (2000) 2003-2010
29. Murphy Jr. G.M., Eng L.F., Ellis W.G., Perry G., Meissner L.C., and Tinklenberg J.R. Antigenic profile of plaques and neurofibrillary tangles in the amygdala in Down's syndrome: a comparison with Alzheimer's disease. Brain Res 537 (1990) 102-108
30. Nie J., McGill M.A., Dermer M., Dho S.E., Wolting C.D., and McGlade C.J. LNX functions as a RING type E3 ubiquitin ligase that targets the cell fate determinant Numb for ubiquitin-dependent degradation. EMBO J 21 (2002) 93-102
31. Nilsson L.N., Arendash G.W., Leighty R.E., Costa D.A., Low M.A., Garcia M.F., et al. Cognitive impairment in PDAPP mice depends on ApoE and ACT-catalyzed amyloid formation. Neurobiol Aging 25 (2004) 1153-1167
32. Nilsson L.N., Bales K.R., DiCarlo G., Gordon M.N., Morgan D., Paul S.M., et al. Alpha-1-antichymotrypsin promotes beta-sheet amyloid plaque deposition in a transgenic mouse model of Alzheimer's disease. J Neurosci 21 (2001) 1444-1451
33. Nishimura T., Fukata Y., Kato K., Yamaguchi T., Matsuura Y., Kamiguchi H., et al. CRMP-2 regulates polarized Numb-mediated endocytosis for axon growth. Nat Cell Biol 5 (2003) 819-826
34. Omar R.A., Chyan Y.J., Andorn A.C., Poeggeler B., Robakis N.K., and Pappolla M.A. Increased expression but reduced activity of antioxidant enzymes in Alzheimer's disease. J Alzheimers Dis 1 (1999) 139-145
35. Palmert M.R., Usiak M., Mayeux R., Raskind M., Tourtellotte W.W., and Younkin S.G. Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease. Neurology 40 (1990) 1028-1034
36. Pereira C., Ferreiro E., Cardoso S.M., and de Oliveira C.R. Cell degeneration induced by amyloid-beta peptides: implications for Alzheimer's disease. J Mol Neurosci 23 (2004) 97-104
37. Roncarati R., Sestan N., Scheinfeld M.H., Berechid B.E., Lopez P.A., Meucci O., et al. The gamma-secretase-generated intracellular domain of beta-amyloid precursor protein binds Numb and inhibits Notch signaling. Proc Natl Acad Sci USA 99 (2002) 7102-7107
38. Rozemuller J.M., Abbink J.J., Kamp A.M., Stam F.C., Hack C.E., and Eikelenboom P. Distribution pattern and functional state of alpha 1-antichymotrypsin in plaques and vascular amyloid in Alzheimer's disease. A immunohistochemical study with monoclonal antibodies against native and inactivated alpha 1-antichymotrypsin. Acta Neuropathol (Berl) 82 (1991) 200-207
39. Santolini E., Puri C., Salcini A.E., Gagliani M.C., Pelicci P.G., Tacchetti C., et al. Numb is an endocytic protein. J Cell Biol 151 (2000) 1345-1352
40. Selkoe D., and Kopan R. Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration. Annu Rev Neurosci 26 (2003) 565-597
41. Shoji M., Golde T.E., Ghiso J., Cheung T.T., Estus S., Shaffer L.M., et al. Production of the Alzheimer amyloid beta protein by normal proteolytic processing. Science 258 (1992) 126-129
42. Smith C.A., Dho S.E., Donaldson J., Tepass U., and McGlade C.J. The cell fate determinant Numb interacts with EHD/Rme-1 family proteins and has a role in endocytic recycling. Mol Biol Cell 15 (2004) 3698-3708
43. Smits H.A., Rijsmus A., van Loon J.H., Wat J.W., Verhoef J., Boven L.A., et al. Amyloid-beta-induced chemokine production in primary human macrophages and astrocytes. J Neuroimmunol 127 (2002) 160-168
44. Styren S.D., Kamboh M.I., and DeKosky S.T. Expression of differential immune factors in temporal cortex and cerebellum: the role of alpha-1-antichymotrypsin, apolipoprotein E, and reactive glia in the progression of Alzheimer's disease. J Comp Neurol 396 (1998) 511-520
45. Susini L., Passer B.J., Amzallag-Elbaz N., Juven-Gershon T., Prieur S., Privat N., et al. Siah-1 binds and regulates the function of Numb. PNAS 98 (2001) 15067-15072
46. Walker D.G., Lue L.F., and Beach T.G. Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia. Neurobiol Aging 22 (2001) 957-966
47. Veerhuis R., Janssen I., De Groot C.J., Van Muiswinkel F.L., Hack C.E., and Eikelenboom P. Cytokines associated with amyloid plaques in Alzheimer's disease brain stimulate human glial and neuronal cell cultures to secrete early complement proteins, but not C1-inhibitor. Exp Neurol 160 (1999) 289-299
48. Vehmas A.K., Kawas C.H., Stewart W.F., and Troncoso J.C. Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease. Neurobiol Aging 24 (2003) 321-331
49. Zhu X., Raina A.K., Lee H.G., Casadesus G., Smith M.A., and Perry G. Oxidative stress signalling in Alzheimer's disease. Brain Res 1000 (2004) 32-39